Metabolism-Clinical and Experimental

Article	Citations
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	918
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	822
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	282
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	244
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation	232
Editorial Board	173
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and High Blood Pressure: Results from CATALYST	162
Editorial Board	162
Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis	160
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	160
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	147
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	143
Molecular code of ferroptosis: emerging multi-dimensional modifications and therapeutic targets in hepatic disorders	137
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	135
Corrigendum to “Emerging roles of arginine metabolism in skeletal health and disease” [Metabolism 2025 Nov 19:175:156451. / PMID: 41270967]	135
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	131
Sarcopenia does not have adverse effects on insulin sensitivity in women with obesity	127
Insulin Resistance: An APOE4 Equivalent for Human Cerebral Cortical Amyloid Deposition	120
Cost–Benefit Management of Insulin Resistance: Combination of Phentermine and a Flexible Weight Loss Strategy in the Era of GLP-1 Agonists. Visible Benefits Shown After Six Months of Treatment	112
Brown adipose tissue-derived metabolites and their role in regulating metabolism	110
The role of active vitamin D in preventing sarcopenia—Authors' reply	104
Sepsis-induced lipid droplet accumulation enhances antibacterial innate immunity through mechanisms dependent on DGAT-1 and interferon-beta	103
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	102
Angiopoietin-like protein 8 mediates inflammation and fibrosis of tubular cells in diabetic kidney disease progression by interacting with Akt2	95
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	90

PCSK9 in metabolism and diseases	88
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	85
PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis	84
Consensus statement on vitamin D role in metabolic health	82
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	80
Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor	77
Protein oxidation in non-exercising healthy adults under varying dietary conditions: Physiological determinants, effects on fuel partitioning, and implications for body weight regulation	77
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	75
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	74
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	74
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	74
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	72
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	71
Comprehensive assessment of the causal effects and metabolite mediators of glucose-lowering drug targets on cardio-renal-liver-metabolic health	70
Editorial Board	70
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	68
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	68
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	66
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	65
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	64
Exercise training increases skeletal muscle sphingomyelinases and affects mitochondrial quality control in men with type 2 diabetes	64
PDAP1 reprograms fatty acid metabolism and drives malignant transformation via HSPA8-Mediated ERK/MAPK activation in hepatocellular carcinoma	63
Metabolic and immune dysfunction at the crossroads between type 1 diabetes and neurodegeneration	61
From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosis	61
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	59
A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis	58
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	57
Role of mitochondria in pathogenesis and therapy of renal fibrosis	56
Role of Coronary Artery Calcium in the Association Between Hormone Replacement Therapy Status and Incident Death and Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis	56
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	56
Editorial Board	56
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	56
Editorial Board	55
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	54
Editorial Board	54
Editorial Board	54
Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment	53
Insulin Resistance as Monitored by Dynamic Light Scattering of Whole Human Serum: An Ancillary Study of PREMIER	53
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016	52
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at	52
The LS-IM score and its relation to direct measurements of insulin resistance	52
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies	51
Clinical and Biochemical Characteristics of Children and Adolescents with Type 1 Diabetes in Mexico	51
Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis	51
Nutritional Management of Patients with Obesity in Critical Care	51
Corrigendum to “Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise” [Metabolism, Volume 168, July 2025, 156	50
NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ	48
Calcitonin and procalcitonin: Revisiting the overlooked role of C cells	47
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	47
Editorial Board	46

NIPSNAP1 and NIPSNAP2 facilitate healthy aging independent of mitophagy	46
Reply to letter regarding the article “Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage	45
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts	43
The heart rate paradox and inferential limits of the GLP-1 receptor agonist–atrial fibrillation association	43
Suppression of hepatosteatosis by isarubrolone C through AMPK-dependent regulation of lipophagy and lipid metabolism	43
Identifying proteins and pathways associated with multimorbidity in 53,026 adults	43
Editorial Board	41
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis	41
Best practice recommendations for the diagnosis and management of hypoparathyroidism	41
New PET Measures of Functional Brain Fractal Dimensions Show Significant Differences for Cortical Grey and White Matter and also in Near Normal vs. Insulin Resistant Patients	40
Association Between Processed and Ultra-processed Food Intake and Cardiovascular Disease and its Risk Factors in Patients with Type 2 Diabetes	40
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort	40
Omentin-1 Levels and Endothelial Dysfunction in Diabetic Kidney Disease	39
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19	39
Commentary on the endocrine society clinical practice guideline on the “treatment of hypercalcemia of malignancy in adults”	38
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis	38
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes	37
Corrigendum to “The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans” [Metab. 97 (2019) 40–49]	37
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation	37
Prevalence of Hypercortisolism in Patients with Difficult-to-control Type 2 Diabetes: Final Results from CATALYST Part 1	37
Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy	37
Response to letter to the editor regarding: “Plasma metabolite profiles of meat intake and their association with cardiovascular disease risk: A population-based study in Swedish cohorts” by Arage et	36
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases	35
Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver	35
Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications	35
Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis	34
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation	34
Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial	34
Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections	34
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy	34
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection	34
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways	32
Folic acid mitigation of alcohol-induced sarcopenia via gut-muscle axis modulation	32
The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions	32
O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36	32
C3aR1 on beta cells preserves beta cell function and glucose homeostasis in diabetic mice by decreasing metabolic stress and dedifferentiation	32
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity	32
Interplay of lipid metabolism and inflammation in podocyte injury	32
Counter-Regulatory Hormone Oscillations, Substrate Competition and Accumulation in the Pathogenesis of Insulin Resistance: A Hypothesis	31
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients	31
MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation - author's reply	31
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study	31
The Role of Insulin Resistance in the Severity of PCOS Among a Population in Albania	31
Changes in Body Composition, Regional Fat Distribution, and Metabolism After Stopping Tirzepatide	30
Blood C-Peptide Values are Impacted by the Collection, Storage and Evaluation Methods	30
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study	30
Sodium-dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled T	30
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis	30
METTL1-mediated m7G methylation of FoxO1 regulates lipid metabolism in metabolic dysfunction-associated fatty liver disease	29
Copper impairs the intestinal barrier integrity in Wilson disease	29
NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway	29
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor	29
Dyslipidemia Correction by Combination of Statin and Choline Fenofibrate in Diabetic Patients with Multifocal Atherosclerosis	29
CSRP3 promotes skeletal muscle remodeling toward aerobic metabolism and enhances exercise endurance through increasing LDHD activity	28
Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation	28
The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression	28
Emerging roles of TRIM in metabolic regulation	28
Effects of Semaglutide on Metabolic Syndrome Parameters in Non-Diabetics: A Meta-analysis of Randomized Controlled Trials	28
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled	28
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response	28
Correlation of Insulin Resistance, Type 2 Diabetes Mellitus, Obesity, and Colorectal Cancer Occurrence	27
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study	27
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank	27
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming	27
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?	27
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980]	27
Propionyl-L-Carnitine in Patients with Type 2 Diabetes and Peripheral Artery Disease	27
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus	27
Myocardial Ischemia in Type 2 Diabetic Patients	27
Editorial Board	27
The Family Heart Foundation Cholesterol Connect® Program: Reducing Gaps in Cardiovascular Risk Factor Awareness through Free At-Home LDL-C and Lipoprotein(a) Screening and Support	27
Aging and metabolism in HFpEF: Pathophysiology and therapeutic implications	27
Metabolomic aging clock predicts risk of different cardiovascular diseases in the UK Biobank	27
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption	27
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models	26
Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study	26
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD	26
The role of histone deacetylases in cardiac energy metabolism in heart diseases	25
Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice	25
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets	25

Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes	25
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease	25
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential	24
Thymoquinone: A Promising Anti-diabetic Molecule!	24
Reply to letter regarding the article “Loss of cardiomyocyte AKT signaling causes deterioration of lipid metabolism and cellular atrophy”	24
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	24
GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies	24
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	23
Effects Of Late Onset Estradiol Treatment On Insulin Resistance And Lipid Metabolism In High-Fat-Fed Ovariectomized Female Mice	23
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	23
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	23
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	23
Prevalence of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes and Cardiovascular Disease: Results from CATALYST	23
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	23
Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury	23
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	23
Reply to: “Precision nutrition in aging: Enhancing frailty prevention through personalized dietary interventions”	22
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	22
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	22
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	22
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	22
Lysine potentiates insulin secretion via AASS-dependent catabolism and regulation of GABA content and signaling	22
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	22
Primary cilia regulate adaptive responses to fasting	22
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	21
Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide	21
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	21
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	21
Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond	21
Liver cancer chronically exposed to palmitate acquires ferroptosis resistance via the downregulation of glutamine-driven hepcidin expression	21
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	21
A Rare Cause of Severe Insulin Resistance: A Case Report	21
FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase	21
ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysis	21
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation	21
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness	21
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	21
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	21
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	21
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice	20
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	20
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway	20
Leptin acutely increases hepatic triglyceride secretion in patients with lipodystrophy	20
Incretin-based therapy and atrial fibrillation risk in overweight or obesity	20
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner	20
Corrigendum to “Current and investigational medications for the treatment of sarcopenia” [Metabolism 2023;149:155597]	19
Alteration of IGF-1 bioavailability due to PAPPA2 deficiency leads to sex-specific metabolic disturbances	19
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential	19
Insulin Resistance Probability Score and Cardiovascular Events in the Elderly	19
Circulating Total and Intact GDF-15 Levels are Not Altered in Response to Weight Loss Induced by Liraglutide and/or Lorcaserin Treatment in Humans with Obesity and/or Diabetes	19
Intravital imaging reveals glucose-dependent cilia movement in pancreatic islets in vivo	19
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression	19
The bone-heart axis: A crucial dialogue in cardiovascular disease	19
Editorial Board	19
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States	19
Meteorin-like protein inhibits vascular smooth muscle cell-derived foam cell formation and atherosclerosis via KIT- endoplasmic reticulum stress signaling	19
Unraveling the roles of mitochondrial sirtuins in aging-related diseases: From mechanistic insights to therapeutic strategies	19
Time-restricted eating and its impact on weight loss, adipose tissue distribution, lean mass and blood pressure in women with cardiometabolic risk factors	19
Expanding the clinical and immunogenomic relevance of SAMD1 in hepatocellular carcinoma	19
Prolonged increase in glutamate whole body and intracellular production in older adults with COPD and healthy controls post-resistance exercise	18
Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient Database	18
The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis	18
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity	18
Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990-2019: An age-period-cohort analysis of the Global Burden of Disease 2019	18
Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice	18
ALDH2 variants – a role in cardiometabolic syndrome	18
COVALENT-111: Durable Glycemic and C-Peptide Improvements with Icovamenib, a Menin Inhibitor Targeting β-Cell Restoration in Insulin-Deficient Type 2 Diabetes	18
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation	18
Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy	18
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss	17
IFT80 and TRPA1 cooperatively regulate bone formation by calcium signaling in response to mechanical stimuli	17
Long Term Effectiveness of the Latest Categories of Antidiabetic Medication for Type 2 Diabetes. Outcomes of the Outpatient Diabetic Clinic of a Tertiary Hospital of Athens	17
Aldosterone Dysregulation and Type 2 Diabetes Mellitus Are Associated with Prevalent Risk of Hypertension: BREAKTHROUGH Risk Study	17
Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation	17
Impact of Insulin Resistance and Chronic Low-Grade Systemic Inflammation on Vascular Rigidity in Patients with Arterial Hypertension and Non-Alcoholic Fatty Liver Disease	17
Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD	17
Essential role of endothelial T-cadherin in the transcytosis of circulating high-molecular-weight adiponectin to sub-vascular tissues	16
Corrigendum to “Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study” [Metabolism, Volume 152, March 2024, 155789]	16
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-I	16
Metabolomics profiles of type 2 diabetes and insulin resistance and their associations with total mortality	16
Adiponectin Gene Variants and their Association with Homa-Index, Adiponectin and Leptin Levels in Adult Metabolic Syndrome Women	16
Editorial Board	16
Metabolaging: a new geroscience perspective linking aging pathologies and metabolic dysfunction	16
Mechanical activation of adipose tissue macrophages mediated by Piezo1 protects against diet-induced obesity by regulating sympathetic activity	16
Corrigendum to “Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1” [Metabolism, Volume 163 (2025), Article Number 156087]	16
A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study	16
Induction of Yin Yang 1 (YY1) overexpression in mature adipocytes promotes dysfunctional adipose tissue and systemic insulin resistance in mice	16
CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status	16
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα	16